Clareo Health | Long-Term Follow-up Safety Study of Human Central Nervous System Stem Cells in Subjects With Geographic Atrophy of Age-Related Macular Degeneration
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
StemCells, Inc.
Age
51–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Must have completed Study CL-N01-AMD
Must be able to provide written informed consent prior to any study related procedures
Agree to comply in good faith with all conditions of the study and to attend all required study visits
You may not be if
Inability to comply with study procedures or visits
Since enrolling in Study CL-N01-AMD, have entered, or are about to enter another investigational study that, in the opinion of the Principal Investigator (PI), might confound study interpretation.
Received off-study immunosuppressive agents in the lead-in study or are receiving any immunosuppressive agents since completing the lead-in study
